SeqCure Immunology AB is developing SeqCureNEO, a cellular immunotherapy method designed to cure advanced cancer. The method is based on a tailor-made and highly potent cell product being manufactured based on each patient’s unique tumor mutations. The cells are then returned to the patient and create an immune response against the tumor.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
